Serum Interleukin-6 Levels Correlate with Malnutrition and Survival in Patients with Advanced Non-Small Cell Lung Cancer
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
AIM: To investigate the level of interleukin-6 in advanced non-small cell lung cancer and to analyze the relationship with malnutrition and survival. METHODS AND STUDY DESIGN: Seventy-one newly diagnosed advanced non-small cell lung cancer patients were enrolled in this prospective study. Malnutrition was defined by using subjective global assessment. Performance status was assessed by the Karnofsky scale. Serum levels of albumin, transferrin, C-reactive protein, lymphocytes/mm3, lactate dehydrogenase and growth hormone were determined before treatment. The patients were followed, and the factors affecting survival were analyzed. RESULTS: The mean follow-up after diagnosis was 180 days. IL-6 levels increased in 48 (68%) of 71 patients. According to the subjective global assessment, 28 (39%) patients were well nourished and 43 (61%) were malnourished. Of the 43 malnourished patients, 29 (41%) were moderately malnourished or suspected of being malnourished and 14 (20%) were severely malnourished. The IL-6 level was related to impaired performance status (P = 0.0001), severe malnutrition (P = 0.004), increased C-reactive protein (P = 0.013), higher growth hormone (P = 0.025) and transferrin (P = 0.03) levels. On univariate analysis, impaired performance status, moderate and severe malnutrition, decreased serum albumin and transferrin, a raised IL-6 and lactate dehydrogenase levels were the significant prognostic factors for survival. Multivariate analysis indicated that a raised IL-6, severe malnutrition and a low serum level of albumin were independent prognostic factors for survival in patients with advanced non-small cell lung cancer. CONCLUSIONS: IL-6 secretion may play a role in the pathophysiology of malnutrition in advanced lung cancer. Results show a relation between elevated IL-6 serum levels and malnutrition, poor performance status, acute phase response and shorter survival in patients affected by advanced non-small cell lung cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, despite other malignancies where there is a clear correlation between IL-6 concentrations and poor prognostic factors [49], such a role in mesothelioma has not been defined.”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [49]
Citations
Cites
What is subjective global assessment of nutritional status?
Detsky, A., McLaughlin, Baker, J., Johnston, N., Whittaker, S., Mendelson, R., & Jeejeebhoy, K. (1987) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860718701100108 · Cited by 3,252
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Regional Lymph Node Classification for Lung Cancer Staging
Mountain, C. F., & Dresler, C. M. (1997) · Chest · doi:10.1378/chest.111.6.1718 · Cited by 1,439
Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984) · Cancer · doi:10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w · Cited by 1,067
Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.
Blay, J., Négrier, S., Combaret, V., Attali, S., Goillot, E., Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J. M., & Jf, M. (1992) · PubMed · Cited by 420
Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas
Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., & Kishimoto, T. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80805-1 · Cited by 411
Assessment of Nutritional Status
Jeejeebhoy, K. N., Detsky, A. S., & Baker, J. P. (1990) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719001400509 · Cited by 308
Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer
Berek, J. S., Chung, C., Kaldi, K., Watson, J. M., Knox, R. M., & Martínez-Maza, O. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90582-c · Cited by 238
Staal-van den Brekel, A. J., Dentener, M. A., Schols, A. M., Buurman, W. A., & Wouters, E. F. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.10.2600 · Cited by 218
Martı́n, F., Santolaria, F., Batista, N., Milena, A., González-Reimers, E., Brito, M. J., & Oramas, J. (1999) · Cytokine · doi:10.1006/cyto.1998.0398 · Cited by 207
Serum levels of interleukin 6 in patients with lung cancer
Yanagawa, H., Sone, S., Takahashi, Y., Haku, T., Yano, S., Shinohara, T., & Ogura, T. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.212 · Cited by 166
Oka, M., Yamamoto, K., Takahashi, M., Hakozaki, M., Abe, T., Iizuka, N., Hazama, S., Hirazawa, K., Hayashi, H., Tangoku, A., et al. (1996) · PubMed · Cited by 159
Zamir, O. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420020052008 · Cited by 134
Interleukin-6 (IL-6) Functions as an Autocrine Growth Factor in Cervical Carcinomas in Vitro
Eustace, D. L. S., Han, X., Gooding, R. P., Rowbottom, A. W., Riches, P., & HEYDERMAN, E. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1156 · Cited by 115
Strassmann, G., Jacob, C. O., Evans, R., Beall, D., & Fong, M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3674 · Cited by 112
Puccio, M., & Nathanson, L. A. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_803 · Cited by 98
NUTRITION THERAPY FOR THE CANCER PATIENT
Shike, M. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70336-1 · Cited by 96
Takizawa, H., Ohtoshi, T., Ohta, K., Yamashita, N., Hirohata, S., Hirai, K., Hiramatsu, K., & Ito, K. (1993) · PubMed · Cited by 94
Serum levels of cytokines in patients with untreated primary lung cancer
Department Medical Oncology (1996) · Lung Cancer · doi:10.1016/s0169-5002(96)80030-4 · Cited by 90
Involvement of lnterleukin-6 in the Elevation of Plasma Fibrinogen Levels in Lung Cancer Patients
Yamaguchi, T., Yamamoto, Y., Yokota, S., Nakagawa, M., Ito, M., & Ogura, T. (1998) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/28.12.740 · Cited by 80
Fearon, K. C. H., Barber, M. D., & Moses, A. G. W. (2001) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30088-7 · Cited by 65
Tumor Anorexia: Causes, Assessment, Treatment
Ollenschläger, G., Viell, B., Thomas, W., Konkol, K., & Bürger, B. (1991) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-84138-5_28 · Cited by 63
Non-small cell lung cancer Part II: Treatment
Ihde, D. C., & Minna, J. D. (1991) · Current Problems in Cancer · doi:10.1016/0147-0272(91)90012-y · Cited by 60
Matsuguchi, T., Okamura, S., Kawasaki, C., Shimoda, K., Omori, F., Hayashi, S., Kimura, N., & Niho, Y. (1991) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1991.tb00135.x · Cited by 47
Somatization, distress and chronic pain
Dworkin, S. F. (1994) · Quality of Life Research · doi:10.1007/bf00433380 · Cited by 46
Zamir, O., Hasselgren, P.-O. J., von Allmen, D., & Fischer, J. E. (1993) · Metabolism · doi:10.1016/0026-0495(93)90036-n · Cited by 39
Clinical Features of Adenosquamous Lung Carcinoma in 127 Patients
Sridhar, K. S., Bounassi, M. J., Raub, W. J., & Richman, S. P. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.1.19 · Cited by 37
Prognostic factors in non-small cell lung cancer: a consensus report
Feld, R. D., Arriagada, R., Ball, D., Mattson, K. V., & S⊘rensen, J. B. (1991) · Lung Cancer · doi:10.1016/0169-5002(91)90003-o · Cited by 34
Autonomous Expressions of Cytokine Genes by Human Lung Cancer Cells and Their Paracrine Regulation
Mizuno, K., Sone, S., Orino, E., Nii, A., & Ogura, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02080.x · Cited by 29
Interleukin-6 production by human melanoma cell lines.
Lee, J. D., Sievers, T. M., Skotzko, M. J., Chandler, C. F., Morton, D., McBride, W. H., & Economou, J. S. (1992) · PubMed · Cited by 22
Research works printed but not linked: 11
- Tan S., 1991, Curr Opin Oncol,, 33, 312
- Lee J.D., 1992, Lymphokine Cytokine Res,, 11, 161
- Berek J.S., 1991, Am J Obstet Gynecol,, 52, 3317
- Takizawa H., 1990, Cancer Res,, 53, 4175
- Gibson R., 1990, Principals of nutrition assessment
- Ihde D.C., 1991, Curr Probab Cancer,, 15, 105
- Oka M., 1996, Cancer Res,, 56, 2776
- Blay J.Y., 1992, Cancer Res,, 52, 3317
- Katsumata N., 1996, Clin Cancer Res,, 2, 553
- Puccio M., 1997, Semin Oncol,, 24, 277
- 10.1038/bjc.1995.212 · DOI · Paper page
Cited by
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 716
Interleukin-6 signaling pathway in targeted therapy for cancer
Guo, Y., Xu, F., Lu, T., Duan, Z., & Zhang, Z. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.007 · Cited by 686
Evaluating the Older Patient with Cancer: Understanding Frailty and the Geriatric Assessment
Kumar Pal, S., Katheria, V., & Hurria, A. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20059 · Cited by 258
Lippitz, B. E., & Harris, R. A. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1093722 · Cited by 248
A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
Bayliss, T. J., Smith, J. T., Schuster, M., Dragnev, K. H., & Rigas, J. R. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.627850 · Cited by 243
“In NSCLC serum IL-6 correlates with malnutrition and diminished overall survival [13].”
Background
Metadata
- Authors
- Songür, N., Kuru, B., Kalkan, F., Özdilekcan, Ç., Çakmak, H., & Hızel, N.
- Affiliations
- Ankara Onkoloji Eğitim ve Araştırma Hastanesi (TR)
- SSK İhtisas Hastanesi (TR)
- Ankara Eğitim ve Araştırma Hastanesi (TR)
- Genome Molecular Diagnosis Laboratory, Ankara, Turkey
- Venue
- Tumori Journal
- Publisher
- SAGE Publications
- Published
- 2004-03
- Volume
- 90
- Issue
- 2
- Pages
- 196-200
- ISSN
- 0300-8916 (ISSN-L)
- 2038-2529
- OpenAlex
- W168170453
- Cited by
- 96
- References
- 32
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 14 · 2019: 3 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 6 · 2014: 11 · 2013: 4 · 2012: 5
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Tumori Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Keywords
- interleukin-6, non-small cell lung cancer, advanced lung cancer, malnutrition, survival, prognostic factors, performance status, serum albumin, transferrin, C-reactive protein, acute phase response, lactate dehydrogenase, growth hormone
- MeSH terms
- Aged, Analysis of Variance, C-Reactive Protein, Carcinoma, Non-Small-Cell Lung, Female, Humans, L-Lactate Dehydrogenase, Lung Neoplasms, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Serum Albumin, Transferrin, Biomarkers, Interleukin-6, Survival Analysis, Karnofsky Performance Status, Human Growth Hormone, Malnutrition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.